Exome sequencing and ATRX are the subject areas of her Mutation study. In her study, Adrienne M. Flanagan carries out multidisciplinary Exome sequencing and Gene research. She conducted interdisciplinary study in her works that combined Gene and ATRX. Pathology is integrated with Malignancy and Lesion in her study. Malignancy and Mutation are two areas of study in which Adrienne M. Flanagan engages in interdisciplinary work. Her research brings together the fields of Aneurysmal bone cyst and Lesion. In her works, she undertakes multidisciplinary study on Aneurysmal bone cyst and Chondroblastoma. Her study in Pathology extends to Chondroblastoma with its themes. Adrienne M. Flanagan undertakes multidisciplinary studies into Genetics and Cancer research in her work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutations of the BRAF gene in human cancer
Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens.
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens;Chris D. Greenman;Beiyuan Fu;Fengtang Yang.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
S Bamford;E Dawson;S Forbes;J Clements.
British Journal of Cancer (2004)
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.
W. Bartlett;J. A. Skinner;C. R. Gooding;R. W. J. Carrington.
Journal of Bone and Joint Surgery-british Volume (2005)
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
M. Fernanda Amary;Krisztian Bacsi;Francesca Maggiani;Stephen Damato.
The Journal of Pathology (2011)
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
Philip Stephens;Chris Hunter;Graham Bignell;Sarah Edkins.
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl.
Nature Genetics (2013)
Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer
Helen Davies;Chris Hunter;Raffaella Smith;Philip Stephens.
Cancer Research (2005)
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
S Vujovic;S Henderson;N Presneau;Edward Odell.
The Journal of Pathology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: